Comparison of Antinuclear Autoantibodies Expression Between COPD and Lung Cancer Patients |Biomedgrid
Journal: American Journal of Biomedical Science & Research (Vol.12, No. 5)Publication Date: 2021-04-27
Authors : Ying Zhang; Zengsheng Chen; Xiaomin Liang; Shuangmei Liu;
Page : 494-500
Keywords : Chronic Obstructive Pulmonary Disease; Lung Cancer; Antinuclear Autoantibodies; Indirect Immunofluorescence; Western Blot Analysis;
Abstract
Circulating antinuclear autoantibodies (ANAs) have been detected in lung cancer patients and chronic obstructive pulmonary disease (COPD) patients as well. The specific differences and significance of ANAs in COPD patients and lung cancer patients remain unclear.
Other Latest Articles
- A Practical External Penile Prosthesis |Biomedgrid
- Neuroanatomical Aspects of Empathy in Decision-Making |Biomedgrid
- Mean Pulmonary Arterial Pressure Decreases with Exposure Time in the Tibet Plateau |Biomedgrid
- Multi Drug Resistant Tuberculosis in Bhutan: A Look into The Line Probe Assay Results |Biomedgrid
- Heart Rate Variability and Perceptual Well-Being in Triathlon – A Case Report |Biomedgrid
Last modified: 2023-08-17 22:05:24